Güler EN, Bozkurt MF, Ozbas S, Yalcin S: Thyroid Cancer. In: Neuroendocrine Tumours: Diagnosis and Management. edn. Edited by Yalcin S, Öberg K. Berlin, Heidelberg: Springer Berlin Heidelberg; 2015: 353–388.
Jegerlehner S, Bulliard J-L, Aujesky D, Rodondi N, Germann S, Konzelmann I, Chiolero A, Group NW. Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study. PLoS ONE. 2017;12(6):e0179387.
Article
Google Scholar
Lin J-D, Hsueh C, Chao T-C. Early Recurrence of Papillary and Follicular Thyroid Carcinoma Predicts a Worse Outcome. Thyroid. 2009;19(10):1053–9.
Article
Google Scholar
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133.
Article
Google Scholar
Quevedo I, Campino C, JA RP, JM EA, C L, C CGG, et al. [Anti thyroglobulin antibodies in the follow up of patients with differentiated thyroid cancer: residual or relapsing disease markers?]. Rev Med Chil. 2002;130(2):167–72.
Article
Google Scholar
Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J. 1869;14(3):146–149.
Pantel K, Alix-Panabières C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med. 2010;16(9):398–406.
Article
Google Scholar
Hanssen A, Wagner J, Gorges TM, Taenzer A, Uzunoglu FG, Driemel C, Stoecklein NH, Knoefel WT, Angenendt S, Hauch S, et al. Characterization of different CTC subpopulations in non-small cell lung cancer. Sci Rep. 2016;6:28010–0.
Article
Google Scholar
Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, et al. Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer. J Clin Oncol. 2005;23(7):1420–30.
Article
Google Scholar
Allen JE, El-Deiry WS. Circulating Tumor Cells and Colorectal Cancer. Curr Colorectal Cancer Rep. 2010;6(4):212–20.
Article
Google Scholar
Winkens T, Pachmann K, Freesmeyer M. Circulating epithelial cells in patients with thyroid carcinoma. Can they be identified in the blood? Clin Endocrinol. 2013;52(1):7–13.
CAS
Google Scholar
Whiting PF, Rutjes AWS, Westwood ME, Susan M, Deeks JJ, Reitsma JB, Leeflang MMG, Sterne JAC, Bossuyt PMM. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.
Article
Google Scholar
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129–35.
Article
Google Scholar
Caroline C, Leeflang MMG, Jessica M, Timothy B, Madhukar P. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012;156(7):500–11.
Article
Google Scholar
Lin J-D, Liou M-J, Hsu H-L, Leong K-K, Chen Y-T, Wang Y-R, Hung W-S, Lee H-Y, Tsai H-J, Tseng C-P. Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer. Thyroid. 2018;28(11):1479–89.
Article
CAS
Google Scholar
Xu JY, Handy B, Michaelis CL, Waguespack SG, Hu MI, Busaidy N, Jimenez C, Cabanillas ME, Fritsche HA Jr, Cote GJ, et al. Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer. J Clin Endocrinol Metab. 2016;101(11):4461–7.
Article
CAS
Google Scholar
Tseng C-P, Leong K-K, Liou M-J, Hsu H-L, Lin H-C, Chen Y-A, Lin J-D. Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma. Oncotarget. 2017;8(44):77453–64.
Article
Google Scholar
Li Y-R, Tseng C-P, Hsu H-L, Lin H-C, Chen Y-A, Chen S-T, Liou M-J, Lin J-D. Circulating epithelial cells as potential biomarkers for detection of recurrence in patients of papillary thyroid carcinoma with positive serum anti-thyroglobulin antibody. Clin Chim Acta. 2018;477:74–80.
Article
CAS
Google Scholar
Qiu ZL, Wei WJ, Sun ZK, Shen CT, Song HJ, Zhang XY, Zhang GQ, Chen XY, Luo QY. Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer. Cell Physiol Biochem. 2018;48(2):718–30.
Article
CAS
Google Scholar
Winkens T, Pachmann K, Freesmeyer M. The influence of radioiodine therapy on the number of circulating epithelial cells (CEC) in patients with differentiated thyroid carcinoma - a pilot study. Experiment Clin Endocrinol Diab. 2014;122(4):246–53.
Article
CAS
Google Scholar
Lin H-C, Liou M-J, Hsu H-L, Hsieh JC-H, Chen Y-A, Tseng C-P, Lin JD. Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma. Oncotarget. 2015;7(13):17242–53.
Article
Google Scholar
Lin J-D, Hsueh C, Chao T-C. Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis. Medicine. 2015;94(26):e1063–3.
Article
Google Scholar
Schmitz-Winnenthal FH, Weckauf H, Haufe S, Hinz U, Z’Graggen K, Klar E, Büchler MW, Weber T. Detection and prognostic relevance of cytokeratin 20 in differentiated and anaplastic thyroid carcinomas by RT-PCR. Surgery. 2003;134(6):964–71.
Article
Google Scholar
Suh I, Filetti S, Vriens MR, Guerrero MA, Tumino S, Wong M, Shen WT, Kebebew E, Duh Q-Y, Clark OH. Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: A SNP array-based linkage analysis of 38 families. Surgery 2009;146(6):1073–1080.
Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, et al. Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis. Cancer Res. 2013;73(7):2059.
Article
CAS
Google Scholar
Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et al. Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer. J Clin Oncol. 2008;26(19):3213–21.
Article
Google Scholar
Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV, Terstappen LWWM. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival. Clin Cancer Res. 2006;12(14):4218.
Article
CAS
Google Scholar
Jueckstock J, Rack B, Friedl TWP, Scholz C, Steidl J, Trapp E, Tesch H, Forstbauer H, Lorenz R, Rezai M, et al. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer – Results of the German SUCCESS-A- trial. BMC Cancer. 2016;16(1):401.
Article
Google Scholar
Huang X, Gao P, Sun J, Chen X, Song Y, Zhao J, Xu H, Wang Z. Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: A meta-analysis. Int J Cancer. 2015;136(1):21–33.
Milas M, Shin J, Gupta M, Novosel T, Nasr C, Brainard J, Mitchell J, Berber E, Siperstein A. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples. Ann Surg. 2010;252(4):643–51.
Article
Google Scholar
Jansen SW, Akintola AA, Roelfsema F, van der Spoel E, Cobbaert CM, Ballieux BE, Egri P, Kvarta-Papp Z, Gereben B, Fekete C, et al. Human longevity is characterised by high thyroid stimulating hormone secretion without altered energy metabolism. Sci Rep. 2015;5:11525–5.
Article
CAS
Google Scholar